BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21655895)

  • 1. Full-length spp24, but not its 18.5-kDa proteolytic fragment, inhibits bone-healing in a rodent model of spine fusion.
    Sintuu C; Simon RJ; Miyazaki M; Morishita Y; Hymanson HJ; Taghavi C; Brochmann EJ; Murray SS; Wang JC
    J Bone Joint Surg Am; 2011 Jun; 93(11):1022-32. PubMed ID: 21655895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells.
    Lee KB; Murray SS; Duarte ME; Spitz JF; Johnson JS; Song KJ; Brochmann EJ; Taghavi CE; Keorochana G; Liao JC; Wang JC
    J Orthop Res; 2011 Nov; 29(11):1712-8. PubMed ID: 21509819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
    Park SB; Park SH; Kim NH; Chung CK
    Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
    Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
    Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxy terminus of secreted phosphoprotein-24 kDa (spp24) is essential for full inhibition of BMP-2 activity.
    Brochmann EJ; Simon RJ; Jawien J; Behnam K; Sintuu C; Wang JC; Murray SS
    J Orthop Res; 2010 Sep; 28(9):1200-7. PubMed ID: 20162696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Coralline Hydroxyapatite Implant with Recombinant Human Bone Morphogenetic Protein-2-Loaded Chitosan Nanospheres and Its Osteogenic Efficacy.
    Xia YJ; Wang W; Xia H; Huang XH; Deng FP; Ying QS; Yu X; Li LH; Wang JH; Zhang Y
    Orthop Surg; 2020 Dec; 12(6):1947-1953. PubMed ID: 33080108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
    Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
    J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
    Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
    Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted phosphoprotein 24 kD inhibits nerve root inflammation induced by bone morphogenetic protein-2.
    Tian H; Li CS; Scott TP; Montgomery SR; Phan K; Lao L; Zhang W; Li Y; Hayashi T; Takahashi S; Alobaidaan R; Ruangchainikom M; Zhao KW; Brochmann EJ; Murray SS; Wang JC; Daubs MD
    Spine J; 2015 Feb; 15(2):314-21. PubMed ID: 25264179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Local Bone Remodeling Effects of rhBMP-2 in an Ovine Interbody Spine Fusion Model.
    Bae HW; Patel VV; Sardar ZM; Badura JM; Pradhan BB; Seim HB; Turner AS; Toth JM
    J Bone Joint Surg Am; 2016 Dec; 98(24):2061-2070. PubMed ID: 28002369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
    Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
    J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.